Showing 410 results

Filters Content type: News, Editors' picks, About HIV Topic: Changing treatment

A change of HIV treatment may be necessary because of side-effects, the development of drug resistance, treatment not being fully effective or because of interactions between HIV drugs and other medications.

Adherence

Second-line ART patients reach viral re-suppression following intensified adherence support

News
13 July 2015
HIV treatment for children & young people

High treatment failure rate among Thai children switching to second-line ART

News
20 April 2015
Treatment guidelines

Dolutegravir and Truimeq approved in England: London guidelines updated

Editor's pick
HIV i-Base
14 January 2015
Health monitoring in resource-limited settings

Sophisticated HIV diagnostics adapted for remote areas

Editor's pick
Science Daily
10 December 2014
Changing treatment

Protease inhibitor monotherapy: darunavir/ritonavir less effective than three-drug therapy

News
7 November 2014
Treatment guidelines

Do emtricitabine and lamivudine have similar virological efficacy when used in first-line HIV therapy?

News
3 November 2014
Side effects

Effective treatments available for HIV patients not eligible for efavirenz regimens

Editor's pick
Science Daily
7 October 2014
Side effects

Switch From Efavirenz to Rilpivirine Quells CNS Toxicity, Improves Sleep

Editor's pick
NATAP
16 September 2014
Resistance

Longer time to virological failure and less drug resistance seen in people taking Atripla than in people taking separate drugs

News
9 September 2014
Changing treatment

Switching from first-line ART with suppressed viral load linked to treatment failure

News
29 July 2014
HIV treatment

Dolutegravir demonstrates good efficacy despite resistance

News
24 July 2014
New & experimental HIV treatments

Therapy with newer, safer antiretrovirals an option for the majority of HIV-positive patients

News
11 July 2014
Adherence

Switch from single-tablet regimen to 3 tablets works in Denmark

Editor's pick
International AIDS Society
10 July 2014
Treatment guidelines

New ARV prescribing guidelines for London (2014)

Editor's pick
HIV i-Base
1 July 2014
Changing treatment

People starting therapy on a boosted protease inhibitor don't need to switch after one virological failure episode, study indicates

News
9 June 2014
Changing treatment

Viral load rebounds in 35% of people using PI/r monotherapy: results of five-year PIVOT study

Editor's pick
HIV i-Base
10 March 2014
Treatment outcomes & life expectancy

Higher pill burden is associated with poorer adherence to HIV therapy and reduced chances of achieving an undetectable viral load

News
31 January 2014
Resistance

Successful HIV drug resistance testing is possible when viral load is low

News
27 January 2014
Changing treatment

U.S. FDA Approves Gilead’s Once-Daily Single Tablet HIV-1 Regimen Complera® for Patients Switching from a Stable Regimen

Editor's pick
Gilead press release
16 December 2013
Treatment guidelines

Systematic review and meta-analysis shows equivalence of 3TC and FTC

News
20 November 2013
New & experimental HIV treatments

Once-daily raltegravir effective as maintenance therapy

News
31 October 2013
Changing treatment

Once-daily raltegravir for 48 weeks as maintenance therapy in Paris

Editor's pick
NATAP
22 October 2013
Bone & joint problems

TDF/FTC-to-ABC/3TC switch maintains viral suppression, eases bone markers

Editor's pick
NATAP
19 September 2013
Changing treatment

Switching From Efavirenz to Rilpivirine Combo Quells CNS Side Effects

Editor's pick
NATAP
13 September 2013